Bolhassani A - Search Results

1

The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.

Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S. Mohit E, et al. Among authors: bolhassani a. Scand J Immunol. 2012 Jan;75(1):27-37. doi: 10.1111/j.1365-3083.2011.02620.x. Scand J Immunol. 2012. PMID: 21916914 Free article.

2

Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.

Bolhassani A, Zahedifard F, Taghikhani M, Rafati S. Bolhassani A, et al. Vaccine. 2008 Jun 19;26(26):3362-70. doi: 10.1016/j.vaccine.2008.03.082. Epub 2008 Apr 18. Vaccine. 2008. PMID: 18471945

3

Heat-shock proteins as powerful weapons in vaccine development.

Bolhassani A, Rafati S. Bolhassani A, et al. Expert Rev Vaccines. 2008 Oct;7(8):1185-99. doi: 10.1586/14760584.7.8.1185. Expert Rev Vaccines. 2008. PMID: 18844593 Free article. Review.

4

The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen.

Bolhassani A, Ghasemi N, Servis C, Taghikhani M, Rafati S. Bolhassani A, et al. Drug Deliv. 2009 May;16(4):196-204. doi: 10.1080/10717540902757721. Drug Deliv. 2009. PMID: 19514980 Free article.

5

Different spectra of therapeutic vaccine development against HPV infections.

Bolhassani A, Mohit E, Rafati S. Bolhassani A, et al. Hum Vaccin. 2009 Oct;5(10):671-89. doi: 10.4161/hv.5.10.9370. Epub 2009 Oct 28. Hum Vaccin. 2009. PMID: 19684468 Review.

6

Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients.

Bolhassani A, Zahedifard F, Taslimi Y, Taghikhani M, Nahavandian B, Rafati S. Bolhassani A, et al. Indian J Med Res. 2009 Nov;130(5):533-41. Indian J Med Res. 2009. PMID: 20090101 Free article.

7

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.

Bolhassani A, Taheri T, Taslimi Y, Zamanilui S, Zahedifard F, Seyed N, Torkashvand F, Vaziri B, Rafati S. Bolhassani A, et al. Exp Parasitol. 2011 Mar;127(3):637-45. doi: 10.1016/j.exppara.2010.12.006. Epub 2010 Dec 25. Exp Parasitol. 2011. PMID: 21187086

8

Improvement of different vaccine delivery systems for cancer therapy.

Bolhassani A, Safaiyan S, Rafati S. Bolhassani A, et al. Mol Cancer. 2011 Jan 7;10:3. doi: 10.1186/1476-4598-10-3. Mol Cancer. 2011. PMID: 21211062 Free PMC article. Review.

9

Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model.

Bolhassani A, Gholami E, Zahedifard F, Moradin N, Parsi P, Doustdari F, Seyed N, Papadopoulou B, Rafati S. Bolhassani A, et al. Exp Parasitol. 2011 May;128(1):9-17. doi: 10.1016/j.exppara.2011.01.012. Epub 2011 Jan 26. Exp Parasitol. 2011. PMID: 21276444

10

Contribution of human neutrophils in the development of protective immune response during in vitro Leishmania major infection.

Safaiyan S, Bolhassani A, Nylen S, Akuffo H, Rafati S. Safaiyan S, et al. Among authors: bolhassani a. Parasite Immunol. 2011 Nov;33(11):609-20. doi: 10.1111/j.1365-3024.2011.01321.x. Parasite Immunol. 2011. PMID: 21793857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters